Back
Amylyx Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
45
AMLX
Amylyx Pharmaceuticals
Last Price:
5.72
Seasonality Move:
6.44%
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.78
Seasonality Move:
-8.12%
Sell
45
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $5.64. The Score for AMLX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.75. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $5.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMLX is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 77.61 | Buy |
| Chaikin Money Flow: | 231331 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 5.04) | Buy |
| Bollinger Bands (100): | (1.62 - 3.68) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 62.6 | Buy |
| Chaikin Money Flow: | 101564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.71) | Buy |
| Bollinger Bands (100): | (0.31 - 1.87) | Sell |
AMLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.24 | Buy |
| 20-day SMA: | 4.41 | Buy |
| 50-day SMA: | 3.36 | Buy |
| 200-day SMA: | 4.86 | Buy |
| 8-day EMA: | 5.19 | Buy |
| 20-day EMA: | 4.56 | Buy |
| 50-day EMA: | 3.69 | Buy |
| 200-day EMA: | 5.82 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Buy |
| 20-day SMA: | 0.64 | Buy |
| 50-day SMA: | 0.59 | Buy |
| 200-day SMA: | 2.68 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.65 | Buy |
| 50-day EMA: | 0.74 | Buy |
| 200-day EMA: | 6.35 | Sell |
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.15 per share, and an increase next year of $1.86 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Amylyx Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||